(MENAFN- EIN Presswire)
Emergen Research Logo
The Pneumatic Nebulizer market is expected to grow from an estimated USD 815.5 million in 2024 to USD 1.47 billion in 2033, at a CAGR of 6.80%
VANCOUVER, BRITISH COLUMBIA, CANADA, January 16, 2025 /EINPresswire / -- The global Pneumatic Nebulizer market is projected to grow from USD 815.5 million in 2024 to USD 1.47 billion by 2033, registering a steady CAGR of 6.80% over the forecast period. This growth is driven by the increasing shift toward home-based healthcare and the rising prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD) and asthma.
Get Free Sample PDF Copy Of This Report@
Key Drivers
Home Healthcare Preference
The rising cost of hospital stays is prompting patients to opt for home-based care. For example, MD Interactive reported in 2021 that the average yearly cost of hospitalization for a COPD patient in the U.S. is USD 19,000. Meanwhile, Community Homecare highlighted that daily hospital stays cost approximately USD 6,200 compared to just USD 135 per home healthcare visit. This shift has led to a growing adoption of breathable medical devices like pneumatic nebulizers.
Rising Respiratory Disorders
Respiratory ailments are becoming increasingly common, fueled by air pollution and higher smoking rates. According to the World Health Organization (WHO), approximately 262 million people had asthma in 2019, with nearly 455,000 deaths attributed to it. Similarly, the Asthma and Allergy Foundation of America reported in 2022 that 25 million people in the U.S. suffer from asthma.
Growing Demand in Emerging Markets
In developing regions, increasing healthcare awareness and access are further boosting the demand for respiratory devices.
Browse Full Report:
Market Segmentation
By Product Type
The market is segmented into breath-actuated nebulizers and vented nebulizers. In 2023, breath-actuated nebulizers held the largest market share due to their enhanced drug delivery and reduced medication waste. FDA approval for advanced products like Verona Pharma's Ohtuvayre in June 2024 underscores the segment's growth potential.
Vented nebulizers are expected to witness the fastest growth during the forecast period, driven by technological advancements that improve drug delivery efficiency and patient compliance.
Some of the key companies in the global Pneumatic Nebulizer Market include:
Beurer GmbH
Besco Medical Co., Ltd.
Bremed Ltd.
Drive DeVilbiss Healthcare
GE HealthCare
Koninklijke Philips N.V.
Morepen Laboratories Ltd.
Nidek Medical Products, Inc.
OMRON Healthcare, Inc.
PARI Pharma
Rossmax International Ltd.
SunMed
Vectura Group plc
Pneumatic Nebulizer Latest Industry Updates
In April 2023, Omron Healthcare announced the launch of their new MicroAir Ultra Compact Nebulizer in the United States. The nebuliser is meant to be tiny and portable, making it ideal for use at home or on the go. It also includes innovative QuietFlow technology, which reduces noise levels and makes it more comfortable for patients to use.
In March 2023, Philips Respironics launched its new InnoSpire Go Nebulizer. The nebuliser is intended to be lightweight and simple to use, making it excellent for children and people with respiratory issues. It also has a revolutionary SmartStart technology, which initiates the nebulisation process when the mask is placed on the face.
Request For Discount:
Pneumatic Nebulizer Market Segmentation Analysis
By Product Type Outlook (Revenue, USD Million; 2020-2033)
Breath-actuated Nebulizer
Vented Nebulizer
By Application Outlook (Revenue, USD Million; 2020-2033)
Chronic Obstructive Pulmonary Disease (COPD)
Asthma
Cystic Fibrosis
Others
By End-user Outlook (Revenue, USD Million; 2020-2033)
Hospitals & Clinics
Home Healthcare
Others
By Regional Outlook (Revenue, USD Million; 2020-2033)
North America
United States
Canada
Mexico
Europe
Germany
France
United Kingdom
Italy
Spain
Benelux
Rest of Europe
Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America
Brazil
Rest of Latin America
Middle East and Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of MEA
Buy Now:
Eric Lee
Emergen Research
+91 90210 91709
...
Visit us on social media:
Facebook
X
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
MENAFN16012025003118003196ID1109098565
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.